- Home
- CPIX vs GRCE Comparison
CPIX vs GRCE Comparison
Compare CPIX & GRCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPIX
- GRCE
- Stock Information
- Founded
- CPIX 1999
- GRCE 2002
- Country
- CPIX United States
- GRCE United States
- Employees
- CPIX N/A
- GRCE N/A
- Industry
- CPIX Biotechnology: Pharmaceutical Preparations
- GRCE
- Sector
- CPIX Health Care
- GRCE
- Exchange
- CPIX Nasdaq
- GRCE NYSE
- Market Cap
- CPIX 35.4M
- GRCE 30.9M
- IPO Year
- CPIX 2009
- GRCE N/A
- Fundamental
- Price
- CPIX $4.64
- GRCE $3.36
- Analyst Decision
- CPIX
- GRCE
- Analyst Count
- CPIX 0
- GRCE 0
- Target Price
- CPIX N/A
- GRCE N/A
- AVG Volume (30 Days)
- CPIX 4.5M
- GRCE 69.2K
- Earning Date
- CPIX 03-04-2025
- GRCE 02-14-2025
- Dividend Yield
- CPIX N/A
- GRCE N/A
- EPS Growth
- CPIX N/A
- GRCE N/A
- EPS
- CPIX N/A
- GRCE N/A
- Revenue
- CPIX $36,785,442.00
- GRCE N/A
- Revenue This Year
- CPIX N/A
- GRCE N/A
- Revenue Next Year
- CPIX N/A
- GRCE N/A
- P/E Ratio
- CPIX N/A
- GRCE N/A
- Revenue Growth
- CPIX N/A
- GRCE N/A
- 52 Week Low
- CPIX $1.04
- GRCE $2.13
- 52 Week High
- CPIX $6.43
- GRCE $4.97
- Technical
- Relative Strength Index (RSI)
- CPIX 83.81
- GRCE N/A
- Support Level
- CPIX $2.08
- GRCE N/A
- Resistance Level
- CPIX $6.43
- GRCE N/A
- Average True Range (ATR)
- CPIX 0.53
- GRCE 0.00
- MACD
- CPIX 0.27
- GRCE 0.00
- Stochastic Oscillator
- CPIX 74.94
- GRCE 0.00
About CPIX Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's primary target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.
About GRCE GRACE THERAPEUTICS INC
Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage.